Holen Sie sich die Stockscreener-App
3.96
1.98%
-0.08
Handel nachbörslich:
3.96
Schlusskurs vom Vortag:
$4.04
Offen:
$4.06
24-Stunden-Volumen:
546.47K
Relative Volume:
0.74
Marktkapitalisierung:
$502.36M
Einnahmen:
$433.14M
Nettoeinkommen (Verlust:
$4.95M
KGV:
110.92
EPS:
0.0357
Netto-Cashflow:
$6.55M
1W Leistung:
-7.69%
1M Leistung:
-18.52%
6M Leistung:
+5.60%
1J Leistung:
+36.55%
1-Tages-Spanne:
$3.89
$4.10
1-Wochen-Bereich:
$3.89
$4.35
52-Wochen-Spanne:
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Firmenname
Organogenesis Holdings Inc
Sektor
Telefon
781-575-0775
Adresse
85 DAN ROAD, CANTON, MA
Vergleichen Sie ORGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.96 | 512.51M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Lake Street | Buy |
| 2024-02-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-08-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
| 2019-04-17 | Eingeleitet | Oppenheimer | Outperform |
| 2019-04-11 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
Does Organogenesis Holdings Inc. fit your quant trading model2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
Is Organogenesis Holdings Inc. stock ready for a breakout2025 Market WrapUp & High Accuracy Trade Signal Alerts - newser.com
Organogenesis Holdings Inc. stock prediction for this week2025 Market Sentiment & Fast Moving Trade Plans - newser.com
What the charts say about Organogenesis Holdings Inc. today2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
Can trapped investors hope for a rebound in Organogenesis Holdings Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
Will Organogenesis Holdings Inc. stock go up soonPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Will Organogenesis Holdings Inc. (2PQ) stock sustain bullish trend into 2025Quarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
How buyback programs support Organogenesis Holdings Inc. (2PQ) stockMarket Activity Summary & Real-Time Stock Price Movement Reports - newser.com
Organogenesis Holdings Inc. stock daily chart insightsWeekly Loss Report & Safe Capital Growth Tips - newser.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - PR Newswire
What analysts say about Organogenesis Holdings Inc 2PQ stockMarket Profile Overview & High Return Investment Ideas - earlytimes.in
Will Organogenesis Holdings Inc. continue its uptrendWall Street Watch & Verified Trade Idea Suggestions - newser.com
Will Organogenesis Holdings Inc. stock see PE expansionJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock considered safe havenVolume Spike & Pattern Based Trade Signal System - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationJuly 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com
Does Organogenesis Holdings Inc. qualify in momentum factor screeningTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Using portfolio simulators with Organogenesis Holdings Inc. includedWatch List & Target Return Focused Picks - newser.com
Measuring Organogenesis Holdings Inc.’s beta against major indicesPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Organogenesis $ORGO Shares Sold by Voya Investment Management LLC - Defense World
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 - The Manila Times
Leading Regenerative Medicine Company Organogenesis to Present Q3 2025 Financial Results and Corporate Update - Stock Titan
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial - MSN
How to monitor Organogenesis Holdings Inc. with trend dashboardsWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Organogenesis Holdings Inc-Aktie (ORGO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 05 '25 |
Buy |
2.91 |
142,379 |
413,625 |
837,437 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
1.54%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):